Overview
Mentions in press and media 5
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Dec 14, 2021 | Cargene Closes a US$19.2M Pre-A Round Led by BioTrack Capital | SINGAPORE and SHANGHAI and BOSTON, Dec. 14, 2021 /PRNewswire/ -- Cargene Biopharma Inc. ("Cargene") announced today the close of an over-subscribed US$19.2 million pre-Series A funding round. The financing was led by BioTrack Capi... |
| Nov 2, 2021 | Carcell Biopharma closes an oversubscribed financing round led by Hyfinity Investments | SINGAPORE, Nov. 2, 2021 /PRNewswire/ -- Carcell Biopharma ("Carcell", the "Company") announced today the close of an over-subscribed financing. The round was led by Hyfinity Investments, with participation from BioTrack ... |
| May 7, 2021 | Oculis closes US$57 million Series C financing | The oversubscribed round was co-led by new investors BVCF Management and Hyfinity Investments, with VI Partners and Wille AG joining the company’s existing investors, Bay City Capital, Brunnur Ventures, EarlyBird, funds managed by Tekla Cap... |
| May 7, 2021 | Oculis closes US$57 million Series C financing |
Reviews 0
FAQ about Hyfinity Investments
What has the press written about Hyfinity Investments?
Parsers VC has collected 5 articles mentioning Hyfinity Investments, among them “Cargene Closes a US$19.2M Pre-A Round Led by BioTrack Capital” (Dec 14, 2021) and “Carcell Biopharma closes an oversubscribed financing round led by Hyfinity Investments” (Nov 2, 2021).
Is Hyfinity Investments still active?
Yes, Hyfinity Investments is active; its latest activity on Parsers VC dates from Dec 14, 2021.